GlobalSurg 3 is now is the final stages of data analysis and manuscript preparation. It has been our biggest and most complex study to date and has relied on the hard work and dedication of literally thousands of individuals all around the world.
The GlobalSurg team have recently been reflecting on quite how much has been achieved in a relatively short period of time – from initial study inception in Johannesburg back in November 2017, to a fully validated dataset of over 16,000 surgical cancer patients less than 2 years later. Not to mention the establishment of a network of >100 National Leads, the development of live data reporting tools, new means of communication with our teams (Podcasts, SlackChats, blogs) and the beginning of the SurgStreet collaboration with the GapMinder Foundation that have happened along the way.
We realise that for teams who joined the study at right at the beginning, it may seem there has been a lag between their contribution of 4-weeks of data in April 2018 and the generation of the results and publications. However, there has been a lot going on in this time! We have put together the figure above to illustrate just how the study has been progressing and how the project management team and data collection teams have been interacting to generate the final, fully validation GlobalSurg 3 dataset.
It been a busy few years for everyone taking part in GlobalSurg 3 but we have learned a lot and established cutting edge tools and techniques in the field of medical data collection on a truly global scale – we hope you’ve enjoyed it as much as we have!